First, this deal will have no impact in the u. S. Business and, therefore, no impact on the amount of supplies procured today. In hops we purchased 8 of the hops in the u. S. We manufactured some but in the open market we purchased 12 of the cans available in the marketplace. We placed 25 of the barley available in the marketplace and all those figures will remain the same pre and post transaction. Bottles, we purchased 27 of whats out there. So thats all those numbers will remain the same and no impact because this transaction is about the rest of the world. Thanks, mr. Chairman. Thank you and Ranking Member klobuchar for having this hearing on a very profoundly important topic. I want to thank our witnesses for being here today, all of you with diverse and different viewpoints. Mr. Brito, thank you for making the trip from connecticut today. We welcome you and thank you for your involvement in our community in connecticut. And i want to say that im a nondrinker, so i have to disclose
Access on cspan, cspan2 cspan radio and cspan. Org. Recently the Federal Reserve and Consumer Financial Protection Bureau removed some lending restrictions on small banks. Next the Senate Banking committee looks at Community Banks and federal regulations. Richard shelby of alabama chairs the hearing. Next the Senate Banking the hearing will come to order. This week the committee here on banking begins an examination of potential changes to the current regulatory structure. Today we will focus on regulatory relief for smaller Financial Institutions. In the near future we will continue this examination by focusing on unnecessary statutory and regulatory impediments across the Financial Services spectrum. While there are some who continue to argue that current law is beyond reproach, there are many on both sides of the aisle that believe improvements can and should be made. Today we will hear from regulators on some of the lessons theyve learned and how best to overcome some of the challe
[ applause ] up next, on s span 3, Community Banking regulations, then discussion on u. S. Infrastructure challenges and the u. S. Supply chain. Later a hearing on freight rail. The Political Landscape has changed with the 114th congress. 43 new republicans and 15 new democrats and 12 new republicans and 1 new democrat, 108 women in congress including the first africanamerican woman in the house and first woman veteran in the senate. Keep track using congressional chronicle on cspan. Org. The page has lots of useful information including Voting Results and statistics about each session of congress. New congress best access on cspan, cspan2 cspan radio and cspan. Org. Recently the Federal Reserve and Consumer Financial Protection Bureau removed some lending restrictions on small banks. Next the Senate Banking committee looks at Community Banks and federal regulations. Richard shelby of alabama chairs the hearing. Next the Senate Banking the hearing will come to order. This week the comm
Challenges we face as a nation and as a people. Of course, businesses does not they dont do it alone. And yes, businesses need the government to protect our security. And to maintain an economic platform of our country. But what Business Needs most of all from all of these Government Agencies is wise, competent and courageous leadership that knows when to get involved and when not to interfere. A government that is judicious and responsible in the exercise of its extraordinary powers to tax, spend and regulate. Today were hearing a lot of talk about socalled economic populism. Its advocates claim they are standing up for the average citizen. But what theyre really standing up for is the unbridaled growth of the Central Government and the development of a state run economy. We have economic populism in this country. And ill tell you what it is. Its 28 million businesses of every conceivable size and endeavor that have sprung to life in every town, city and community in our country. Its
16. Im happy to. Nkats, now just three years old, was the first new center at nih again, quite a long time and was focused in trying to identify the bottle necks from going from basic science discoveries to benefits. In collaboration with our partners in the private sector. I think initially there were some concerns that nih is becoming a drug company, that really was never the plan and is not happening now. Instead, we are identifying areas of Technology Development that no Single Company could undertake, but working with them, we can give you just one example. The effort to try to figure out when youre developing a new drug, whether its going to be safe in humans or not. Has been a real difficult one. We use animal studies, small animals, large animals. Its not that accurate. Its slow, its expensive. We probably lose drugs along the way because some mouse got a slight liver issue and it probably would have had no relevance to humans but we sort of lose the drug at that point. Wouldnt